Europe Safety Syringes Market

Europe Safety Syringes Market Size

The safety syringes market size in Europe was worth USD 1.65 Billion in 2023. The European market is further predicted to reach USD 3.29 Billion by 2032 from USD 1.78 billion in 2024, growing at a CAGR of 7.97% from 2024 to 2032.

Safety syringes have a built-in safety mechanism designed to protect healthcare workers from accidental needle stick/ prick injuries. There has been tremendous growth in the market for the past several years, owing to their main safety feature, which can be detached or permanently removed. Pre-filled syringes could help ensure that the right medicine is delivered with precision and at the right dosage, dramatically reducing the risk of medical errors. Furthermore, these syringes are very patient-friendly, especially for self-injections for ailments like insulin injections, artificial hormone therapies, and other medications, The European Biosafety Network has recently found lowered safety precautions, demonstrating the need for safety syringes for improved safety.

MARKET DRIVERS

The growing number of needle stick injury cases, favorable reimbursement policies, and the high number of hospitals and clinics in Europe are propelling the safety syringe market growth in Europe. In addition, several countries have introduced regulations to ensure the mandatory use of safety syringes to reduce needlestick injuries and avoid needle reuse. These regulations have increased the demand for safe syringes and moved the focus of medical device manufacturers on safe syringes over conventional syringes. Furthermore, the increase in hospitalization rate and high incidences of acute/chronic diseases is anticipated to drive the European safety syringes market during the forecast period.

MARKET RESTRAINTS

Factors such as the high cost of safety syringes compared to conventional syringes, the availability of alternative drug delivery methods such as patches and vacuum injections, and decreased healthcare expenses in some European regions, are limiting the market's growth. In addition, the lack of awareness about products is also anticipated to hamper the European safety syringes market during the forecast period.

REGIONAL ANALYSIS

Europe is a promising regional segment for safety syringes worldwide and accounted for a substantial share of the global market in 2023.

In 2023, the UK safety syringes market represented the largest share of the European safety syringes market, followed by Germany. A well-established healthcare infrastructure, good disposable income, a high number of needle stick injuries, and increased healthcare awareness are significant drivers of the North American safety syringe market. Public expenditure on health as a percentage of GDP in the United Kingdom has increased with the development in the healthcare sector. In 2020, annual public health expenditure in the United Kingdom was 10.53% of GDP. This is a big jump from the previous year and the highest ratio in the period considered.

The safety syringes market in Germany is expected to exhibit the highest CAGR during the forecast period due to the increasing population, increasing prevalence of diabetes, and increased awareness of acute injuries. In 2016, health spending in Germany was 11.6% of GDP, above the EU average of 9.9%. Furthermore, the growing preference for the painless safety needle is drawing attention from many international market players and is estimated to provide lucrative growth opportunities. In addition, government syringe disposal programs are also expected to contribute to the regional market growth.

The Italian safety syringes market is estimated to capture a considerable share of the European market during the forecast period. In 2020, the population aged 65 and over in Italy was 23.8%. The Italian population aged 65 and over increased to 23.6% in 2020. The rising cost of healthcare and increasing availability of safety needles in the market are the significant factors expected to aid the growth of the Italian safety needles market. In addition, the increase in the manufacture and development of safety syringe technology is also expected to drive the growth of the safety syringe market in the region. Moreover, the high number of hospitals and growing cases of chronic ailments are other factors in developing the Italian safety syringes market.

At the same time, the safety syringes market in Spain is expected to record a promising CAGR during the forecast period.  Further, the growing demand for prefilled syringes fortified with safety features in this region also adds to the market growth.

KEY MARKET PLAYERS

A few prominent companies operating in the European safety syringes market profiled in this report are Covidien plc, Retractable Technologies Inc., Becton, Dickinson & Company, Terumo Corporation, Unilife Revolutions Medical Corporation, Smiths Medical, Sol-Millennium, Ultimed Inc., and Axel Bio Corporation.

MARKET SEGMENTATION

This research report on the European safety syringes market is segmented and sub-segmented into the following categories.

 By Technology

• Retractable Safety Syringes
• Non-Retractable Safety Syringes

 By Therapy

• Insulin
• GLP-1
• Tuberculosis
• Growth Hormones

 By End Users

• Hospitals
• Home Care

 By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe